Technology that lights up cells to enable study of the effects of drugs and monitor disease is among The Scientist magazine’s top 10 innovations of 2013. It’s also a University of Tennessee technology and licensed by a Knoxville-based startup company.
Treatment for age-related macular degeneration, technology to alert nurses when a newborn patient’s endotracheal tube tip is out of position and a sensor to check for contaminates in jet fuel are among the recipients of funding from the University of Tennessee Research Foundation.
Not all new technologies created by University of Tennessee researchers are ready for the marketplace. To help inventors get their products closer to licensing and commercialization, the UT Research Foundation awards grants each year through its annual maturation funding program.
University of Tennessee faculty researchers Gabor Tigyi and Tami Wyatt are the winners of the B. Otto and Kathleen Wheeley Award for Excellence in Technology Transfer presented by the UT Research Foundation.
A group of researchers at the University of Tennessee Graduate School of Medicine in Knoxville has created technology that provides non-invasive detection of amyloidosis, a disease known to occur in Type 2 diabetes, myeloma, rheumatoid arthritis, Alzheimer’s and other fatal or debilitating diseases. Currently there is no detection for amyloidosis available in the U.S., and the median survival rate is four years.